3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2/3
1
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
9
Other
1
Conditions
Obesity
5
Mucositis
4
Stomatitis
3
Dyspnea
3
Polycystic Ovary Syndrome
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Progesterone Resistance
1
Pain
1
Overweight
1
Oropharyngeal Neoplasms
1
Oral Ulcer
1
Opioid-Induced Constipation
1
Neoplasms
1
Motor Activity
1
Lymphoma, Follicular
1
Infertility
1
Hypoxia
1
Fatty Liver
1
Endometrial Hyperplasia
1
Constipation
1
Breast Neoplasms
1
Acidosis, Respiratory
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Oropharyngeal Neoplasms
×
Other
×
Clear all
NCT04648020
2023-05-31
VOICE
Monopar Therapeutics
Phase 2/3
Terminated
190 enrolled